Immunomedics (IMMU) – Hot Corp. News
-
Gilead Sciences (GILD) to Acquire Immunomedics (IMMU) for $21 Billion
-
Immunomedics (IMMU) Phase 3 ASCENT Study of TRODELVY in Previously-Treated Patients with mTNBC Met Primary Endpoint
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to IMMU Stock Lookup